PMH48 VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA
Abstract
Authors
C Graham J Mauskopf AH Lawson H Ascher-Svanum D Bruhn PR Watson
C Graham J Mauskopf AH Lawson H Ascher-Svanum D Bruhn PR Watson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now